Pneumococcal Vaccine in Untreated CLL Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
- Status
- RECRUITING
- Phase
- N/A
A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion
- Status
- COMPLETED
- Phase
- PHASE2
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Status
- RECRUITING
- Phase
- PHASE1
Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1
BR in Patients With CLL With Comorbidities and/or Renal Dysfunction
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- Status
- RECRUITING
- Phase
- PHASE3
Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Evaluate the Safety and Efficacy of TGR 1202 in Patients With Relapsed or Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- N/A
Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL
- Status
- TERMINATED
- Phase
- PHASE1
Open-label Extension Study in Patients 65 Years or Older With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3